Abstract
Background/Objectives: Clinical and psychological factors associated with glycemic response to continuous glucose monitoring (CGM)-supported care remain incompletely understood in adults with long-standing type 2 diabetes (T2D) receiving intensive insulin therapy. This study examined their associations with six-month glycemic response in routine clinical practice. Methods: This prospective observational study included 225 adults initiating CGM alongside structured education and individualized treatment optimization at a tertiary diabetes center. Composite response was defined as an HbA1c reduction of ≥0.5 percentage points from baseline to six months and/or a time in range (TIR) increase of ≥10 percentage points between months three and six. Exploratory complete-case logistic regression examined clinical characteristics, three-month TIR, and baseline self-efficacy, motivation, and depressive symptoms. Results: Mean age was 66.1 ± 9.0 years, and baseline HbA1c was 8.54 ± 1.86%. The HbA1c response criterion was achieved by 91 of 146 participants (62.3%), and the TIR criterion by 32 of 147 (21.8%). Among 140 participants with evaluable composite outcomes, 97 (69.3%) were responders. Higher baseline HbA1c was associated with composite response (clinical model OR 5.40, 95% CI 2.68–10.88). Self-efficacy, motivation, and depressive symptoms showed no statistically significant associations in the adjusted model. Conclusions: Approximately seven in ten participants with evaluable outcomes achieved a composite glycemic response during CGM-supported care. Higher baseline HbA1c was associated with response, while the psychological measures assessed did not clearly distinguish responders after adjustment. These findings provide insight into response within a structured care pathway for adults with long-standing T2D receiving intensive insulin therapy and warrant confirmation in larger cohorts.